Domů › Crohnova choroba › Pennsylvania › Philadelphia
Klinické studie Crohnova choroba v Philadelphia, PA
13 studií pro Crohnova choroba hledá účastníky v lokalitách v Philadelphia a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Probíhá náborFáze 3
- Thomas Jefferson University Hospital ( Site 5133), Philadelphia
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Probíhá náborFáze 2
- University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 265904, Philadelphia
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Probíhá náborFáze 3
- Children's Hospital of Philadelphia, Philadelphia
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Probíhá náborFáze 2/3
- University of Pennsylvania, Philadelphia
- Jefferson Digestive Health Institute, Philadelphia
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Probíhá náborFáze 3
- Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Probíhá náborFáze 3
- University of Pennsylvania School of Medicine-Site Number: 8400072, Philadelphia
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Probíhá náborFáze 3
- University of Pennsylvania School of Medicine-Site Number: 8400072, Philadelphia
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Probíhá náborFáze 3
- Children's Hospital of Philadelphia (CHOP), Philadelphia
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Probíhá náborFáze 3
- Children's Hospital of Philadelphia, Philadelphia
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
Probíhá náborFáze 3
- Children's Hospital of Philadelphia - Main /ID# 262197, Philadelphia
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
Probíhá náborFáze 4
- Children's Hospital of Philadelphia, Philadelphia
Precise Infliximab Exposure and Pharmacodynamic Control
Probíhá náborFáze 2/3
- Nemours Children's Health System-Wilmington, Wilmington · Vzdálenost 25 mi
Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial
Probíhá nábor
- Children's Hospital of Philadelphia, Philadelphia
Studie Crohnova choroba v jiných městech
- New York City, NY35 studií
- Boston, MA19 studií
- Miami, FL19 studií
- Cleveland, OH19 studií
- St. Louis, MO19 studií
- Tyler, TX17 studií
- Houston, TX17 studií
- Orlando, FL17 studií
- Atlanta, GA17 studií
- San Antonio, TX15 studií
- San Diego, CA15 studií
- Los Angeles, CA15 studií
Další studie v Philadelphia
- Rakovina (všechny typy)59 studií
- Rakovina prsu56 studií
- Nemalobuněčný plicní karcinom51 studií
- Metastatický karcinom46 studií
- Rakovina prostaty44 studií
- Kolorektální karcinom44 studií
- Rakovina vaječníků44 studií
- Rakovina plic36 studií
- Akutní myeloidní leukemie34 studií
- Srdeční selhání31 studií
- Rakovina endometria28 studií
- Deprese26 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.